Press

Field Trip Health opens Europe’s first psychedelic therapy healthcare facility

Sep 7 • 3 min read

Quick Take: The facility will offer a team of psychiatrists and nurses to help guide patients in psychedelic therapy. Field Trip Health (TSX: FTRP), the world’s first facility for psychedelic-assisted psychotherapy, is thrilled to announce the opening of its new branch in Amsterdam. At Field Trip, a dedicated team of professionals, including psychiatrists, and nurses, guide people…

Filament Health Shares to Commence Trading on the OTC Market

Sep 7 • 3 min read

Quick Take: Filament has recieved approval from the Financial Regulatory Authority that it is qualified to begin trading on the OTC Pink Market. Filament Health Corp. (NEO: FH) (OTC Pink: FLHLF), an exclusively-natural psychedelic drug discovery company, today announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on…

MINDCURE Announces Financial Results for Fiscal 2021

Sep 3 • 3 min read

VANCOUVER, BC, August 31, 2021 – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research in psychedelics, today announced its financial results for the three and twelve months ended May 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated. …

Filament Health Files 20th Patent Application Including Three International Pct Applications

Sep 3 • 2 min read

Vancouver, British Columbia, September 1, 2021 – Filament Health Corp. NEO:FH. (“Filament” or the “Company”), a leading exclusively-natural psychedelic drug development company, today announced that it has filed its 20th patent application in support of the Company’s research phase programs. These filings include three international Patent Cooperation Treaty (PCT) patent applications. “This milestone sets us ahead of…

Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers

Sep 3 • 5 min read

Quick Take: The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip’s medical teams for screening, prescribing and administration of ketamine. Field Trip Health Ltd. (Nasdaq: FTRP), a leader in the development and delivery of psychedelic therapies, is pleased to…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441